首页 > 最新文献

Journal of VitreoRetinal Diseases最新文献

英文 中文
Clinical Profiles of Retinal Vasoproliferative Tumors. 视网膜血管增生性肿瘤的临床概况。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-14 DOI: 10.1177/24741264241296464
Brughanya Subramanian, Purna Nangia, Pukhraj Rishi, Jaydeep Avinash Walinjkar, Dhanashree Ratra, Jaya Prakash Vadivelu, Parthopratim Dutta Majumder, Jyotirmay Biswas, Rajiv Raman

Purpose: To describe the clinical features and treatment outcomes of patients with retinal vasoproliferative tumors. Methods: This retrospective case series comprised patients diagnosed with a retinal vasoproliferative tumor. Electronic medical records were reviewed, and patients' demographic details, clinical presentation, and treatment outcomes were analyzed. Results: Nineteen eyes of 19 patients with vasoproliferative tumors were included. The mean age (±SD) at presentation was 37.0 ± 16.95 years. No eye had bilateral tumors, and 1 eye had multiple tumors. Three eyes (15%) had primary tumors, while 16 (84%) had secondary tumors. Primary tumors mainly affected the inferotemporal quadrant (n = 3). Secondary tumors involved the inferior quadrant (n = 4), inferotemporal quadrant (n = 5), and inferonasal quadrant (n = 5). Secondary tumors were associated with Coats disease (n = 6), intermediate uveitis (n = 3), traumatic chorioretinopathy (n = 2), familial exudative vitreoretinopathy (n = 2), retinal vasculitis (n = 2), and retinal vascular occlusion (n = 1). Retinochoroidal features included intraretinal and subretinal exudates, subretinal fluid, intraretinal hemorrhaging, vitreous hemorrhaging, cystoid macular edema, vitritis, preretinal fibrosis, dilated feeding vessel, epiretinal membranes, and tractional retinal detachment. Treatment modalities included cryotherapy, laser photocoagulation, and local steroids. The mean follow-up was 25.3 months, during which 18 eyes had tumor regression and 1 had a worsening condition. Conclusions: Secondary vasoproliferative tumors were more frequently observed than primary tumors, often presenting as unilateral, unifocal tumors situated posterior to the equator in the inferior fundus. Conventional treatment approaches, such as cryotherapy and laser photocoagulation, were effective at tumor regression and often required multiple sessions.

目的:描述视网膜血管增生性肿瘤患者的临床特征和治疗效果。方法:该回顾性病例系列包括确诊为视网膜血管增生性肿瘤的患者。回顾电子病历,分析患者的人口统计学细节、临床表现和治疗结果。结果共纳入19名血管增生性肿瘤患者的19只眼睛。发病时的平均年龄(±SD)为 37.0±16.95 岁。没有一只眼为双侧肿瘤,有一只眼为多发性肿瘤。3只眼睛(15%)患有原发性肿瘤,16只眼睛(84%)患有继发性肿瘤。原发性肿瘤主要累及颞下象限(n = 3)。继发性肿瘤累及下象限(4 例)、颞下象限(5 例)和颞下象限(5 例)。继发性肿瘤与Coats病(6例)、中间葡萄膜炎(3例)、外伤性脉络膜视网膜病变(2例)、家族性渗出性玻璃体视网膜病变(2例)、视网膜血管炎(2例)和视网膜血管闭塞(1例)有关。视网膜脉络膜特征包括视网膜内和视网膜下渗出物、视网膜下积液、视网膜内出血、玻璃体出血、囊样黄斑水肿、玻璃体炎、视网膜前纤维化、进血管扩张、视网膜上膜和牵引性视网膜脱离。治疗方法包括冷冻疗法、激光光凝和局部类固醇。平均随访时间为 25.3 个月,其中 18 只眼睛肿瘤消退,1 只眼睛病情恶化。结论是继发性血管增生性肿瘤比原发性肿瘤更常见,通常表现为单侧、单灶肿瘤,位于眼底下部赤道后方。冷冻疗法和激光光凝等常规治疗方法对肿瘤消退有效,但往往需要多次治疗。
{"title":"Clinical Profiles of Retinal Vasoproliferative Tumors.","authors":"Brughanya Subramanian, Purna Nangia, Pukhraj Rishi, Jaydeep Avinash Walinjkar, Dhanashree Ratra, Jaya Prakash Vadivelu, Parthopratim Dutta Majumder, Jyotirmay Biswas, Rajiv Raman","doi":"10.1177/24741264241296464","DOIUrl":"10.1177/24741264241296464","url":null,"abstract":"<p><p><b>Purpose:</b> To describe the clinical features and treatment outcomes of patients with retinal vasoproliferative tumors. <b>Methods:</b> This retrospective case series comprised patients diagnosed with a retinal vasoproliferative tumor. Electronic medical records were reviewed, and patients' demographic details, clinical presentation, and treatment outcomes were analyzed. <b>Results:</b> Nineteen eyes of 19 patients with vasoproliferative tumors were included. The mean age (±SD) at presentation was 37.0 ± 16.95 years. No eye had bilateral tumors, and 1 eye had multiple tumors. Three eyes (15%) had primary tumors, while 16 (84%) had secondary tumors. Primary tumors mainly affected the inferotemporal quadrant (n = 3). Secondary tumors involved the inferior quadrant (n = 4), inferotemporal quadrant (n = 5), and inferonasal quadrant (n = 5). Secondary tumors were associated with Coats disease (n = 6), intermediate uveitis (n = 3), traumatic chorioretinopathy (n = 2), familial exudative vitreoretinopathy (n = 2), retinal vasculitis (n = 2), and retinal vascular occlusion (n = 1). Retinochoroidal features included intraretinal and subretinal exudates, subretinal fluid, intraretinal hemorrhaging, vitreous hemorrhaging, cystoid macular edema, vitritis, preretinal fibrosis, dilated feeding vessel, epiretinal membranes, and tractional retinal detachment. Treatment modalities included cryotherapy, laser photocoagulation, and local steroids. The mean follow-up was 25.3 months, during which 18 eyes had tumor regression and 1 had a worsening condition. <b>Conclusions:</b> Secondary vasoproliferative tumors were more frequently observed than primary tumors, often presenting as unilateral, unifocal tumors situated posterior to the equator in the inferior fundus. Conventional treatment approaches, such as cryotherapy and laser photocoagulation, were effective at tumor regression and often required multiple sessions.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241296464"},"PeriodicalIF":0.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serpiginous Choroiditis After COVID-19 Infection. COVID-19 感染后的浆液性脉络膜炎
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-14 DOI: 10.1177/24741264241297936
Sorayya Seddigh, Ashlyn Pinto, Amr M Zaki, R Rishi Gupta

Purpose: To present the first case of macular serpiginous choroiditis after COVID-19 infection. Methods: A single case was analyzed. Results: A 28-year-old previously healthy man presented with severe unilateral vision loss in the left eye. A fundus examination showed severe atrophic pigmentary changes that corresponded with optical coherence tomography (OCT) findings of a rapidly progressing amoeboid-like lesion disrupting the ellipsoid zone and retinal pigment epithelium. Multimodal imaging, including fundus autofluorescence, OCT angiography, and indocyanine green angiography, was supportive of serpiginous choroiditis. After a comprehensive systemic workup, the diagnosis of macular serpiginous choroiditis was confirmed. No improvement was seen with high-dose steroids; therefore, an immunosuppressive regimen was initiated. Conclusions: An exaggerated choroidal inflammatory response may be triggered by a COVID-19 infection, although causation cannot be inferred. Retinal manifestations should be considered when assessing patients presenting with visual symptoms after COVID-19 infection.

目的:介绍首例感染 COVID-19 后出现黄斑浆液性脉络膜炎的病例。方法:对一个病例进行分析:分析一个病例。结果一名 28 岁的健康男性左眼单侧视力严重下降。眼底检查发现严重的萎缩性色素改变,与光学相干断层扫描(OCT)发现的快速进展的阿米巴样病变相吻合,破坏了椭圆体区和视网膜色素上皮。包括眼底自动荧光、OCT 血管造影和吲哚菁绿血管造影在内的多模态成像支持浆液性脉络膜炎。经过全面的系统检查,确诊为黄斑浆液性脉络膜炎。使用大剂量类固醇治疗后,病情未见好转,因此开始使用免疫抑制剂。结论COVID-19感染可能会诱发脉络膜炎症反应,但无法推断其因果关系。在评估感染 COVID-19 后出现视觉症状的患者时应考虑视网膜表现。
{"title":"Serpiginous Choroiditis After COVID-19 Infection.","authors":"Sorayya Seddigh, Ashlyn Pinto, Amr M Zaki, R Rishi Gupta","doi":"10.1177/24741264241297936","DOIUrl":"10.1177/24741264241297936","url":null,"abstract":"<p><p><b>Purpose:</b> To present the first case of macular serpiginous choroiditis after COVID-19 infection. <b>Methods:</b> A single case was analyzed. <b>Results:</b> A 28-year-old previously healthy man presented with severe unilateral vision loss in the left eye. A fundus examination showed severe atrophic pigmentary changes that corresponded with optical coherence tomography (OCT) findings of a rapidly progressing amoeboid-like lesion disrupting the ellipsoid zone and retinal pigment epithelium. Multimodal imaging, including fundus autofluorescence, OCT angiography, and indocyanine green angiography, was supportive of serpiginous choroiditis. After a comprehensive systemic workup, the diagnosis of macular serpiginous choroiditis was confirmed. No improvement was seen with high-dose steroids; therefore, an immunosuppressive regimen was initiated. <b>Conclusions:</b> An exaggerated choroidal inflammatory response may be triggered by a COVID-19 infection, although causation cannot be inferred. Retinal manifestations should be considered when assessing patients presenting with visual symptoms after COVID-19 infection.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241297936"},"PeriodicalIF":0.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ischemic Retinopathy Associated With Mantle Cell Lymphoma-Induced Vascular Occlusion. 与套细胞淋巴瘤诱发的血管闭塞有关的缺血性视网膜病变
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-13 DOI: 10.1177/24741264241297945
Christopher A Turski, Gunay Uludag Kirimli, Lejla Vajzovic, Stephen Scott, Majda Hadziahmetovic

Purpose: To describe a patient with bilateral ischemic retinopathy, likely attributable to vascular occlusion induced by mantle cell lymphoma. Methods: A case and its findings were analyzed. Results: A 54-year-old man presented with an 11-month history of significant vision loss in both eyes. His medical history was significant for mantle cell lymphoma with no signs of intraorbital involvement on magnetic resonance imaging. At presentation, the visual acuity was 20/400 OD and counting fingers OS, with an unremarkable anterior segment examination. On fundoscopy, optic nerve pallor, sclerotic blood vessels, and cotton-wool spots were seen. Profound retinal nonperfusion and inner retinal layer loss were confirmed with fluorescein angiography and optical coherence tomography, with no signs of macular edema at the time of presentation. Conclusions: This report represents the first instance of bilateral ischemic retinopathy, likely originating from mantle cell lymphoma, presenting predominantly with ischemic retinal features and resulting in profound vision loss. With few cases documenting retinal involvement in mantle cell lymphoma, this report provides a better understanding of this rare pathology and its effect on retinal health.

目的:描述一名双侧缺血性视网膜病变患者的情况,其病因可能是套细胞淋巴瘤诱发的血管闭塞。方法:对一个病例及其研究结果进行分析:对一个病例及其研究结果进行分析。结果:一名 54 岁的男子在 11 个月前出现双眼视力明显下降。他的病史中有明显的套细胞淋巴瘤,磁共振成像没有发现眶内受累的迹象。就诊时,外侧视力为 20/400,外侧为数指,眼前节检查无异常。眼底镜检查可见视神经苍白、血管硬化和棉絮斑。荧光素血管造影和光学相干断层扫描证实了严重的视网膜非灌注和视网膜内层缺失,但发病时没有黄斑水肿的迹象。结论:本报告是首例双侧缺血性视网膜病变,很可能源自套细胞淋巴瘤,主要表现为缺血性视网膜特征,并导致视力严重下降。由于很少有病例记录套细胞淋巴瘤累及视网膜,本报告让人们更好地了解了这种罕见病变及其对视网膜健康的影响。
{"title":"Ischemic Retinopathy Associated With Mantle Cell Lymphoma-Induced Vascular Occlusion.","authors":"Christopher A Turski, Gunay Uludag Kirimli, Lejla Vajzovic, Stephen Scott, Majda Hadziahmetovic","doi":"10.1177/24741264241297945","DOIUrl":"10.1177/24741264241297945","url":null,"abstract":"<p><p><b>Purpose:</b> To describe a patient with bilateral ischemic retinopathy, likely attributable to vascular occlusion induced by mantle cell lymphoma. <b>Methods:</b> A case and its findings were analyzed. <b>Results:</b> A 54-year-old man presented with an 11-month history of significant vision loss in both eyes. His medical history was significant for mantle cell lymphoma with no signs of intraorbital involvement on magnetic resonance imaging. At presentation, the visual acuity was 20/400 OD and counting fingers OS, with an unremarkable anterior segment examination. On fundoscopy, optic nerve pallor, sclerotic blood vessels, and cotton-wool spots were seen. Profound retinal nonperfusion and inner retinal layer loss were confirmed with fluorescein angiography and optical coherence tomography, with no signs of macular edema at the time of presentation. <b>Conclusions:</b> This report represents the first instance of bilateral ischemic retinopathy, likely originating from mantle cell lymphoma, presenting predominantly with ischemic retinal features and resulting in profound vision loss. With few cases documenting retinal involvement in mantle cell lymphoma, this report provides a better understanding of this rare pathology and its effect on retinal health.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241297945"},"PeriodicalIF":0.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage. 抗血管内皮生长因子注射液用于慢性治疗黄斑脱离、眼窝脱离伴玻璃体出血的糖尿病牵拉性视网膜脱离。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-12 DOI: 10.1177/24741264241297684
Melissa Yuan, Sandra Hoyek, Leo A Kim, Celine Chaaya, Nimesh Patel

Purpose: To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. Methods: A case report was evaluated. Results: A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. Conclusions: In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.

目的:评估使用抗血管内皮生长因子(anti-VEGF)治疗涉及黄斑的牵引性视网膜脱离(TRD)的效果。方法:评估一份病例报告:对一份病例报告进行评估。结果:一名 40 岁男子因先天性心脏病和增殖性糖尿病视网膜病变导致视力下降。由于医疗原因,手术并不可行,而全视网膜光凝又受到视网膜牵引和出血的限制。尽管最初双侧黄斑-关闭、眼窝-开启的TRD有所进展,但患者仍接受了每8至12周定期进行的玻璃体内(IVT)贝伐单抗治疗。最初病情有所好转后,在超过1.5年的随访中,双眼的视网膜仍保持解剖学上的稳定。结论是在无法进行手术的情况下,通过重复IVT抗血管内皮生长因子注射单药治疗,可以成功控制伴有新生血管的黄斑受累TRD。
{"title":"Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage.","authors":"Melissa Yuan, Sandra Hoyek, Leo A Kim, Celine Chaaya, Nimesh Patel","doi":"10.1177/24741264241297684","DOIUrl":"10.1177/24741264241297684","url":null,"abstract":"<p><p><b>Purpose:</b> To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. <b>Methods:</b> A case report was evaluated. <b>Results:</b> A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. <b>Conclusions:</b> In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241297684"},"PeriodicalIF":0.5,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021. 医保报销和玻璃体视网膜手术服务量的趋势:2000 年至 2021 年。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-08 DOI: 10.1177/24741264241292743
Eric S Li, Ron A Adelman

Purpose: To characterize trends in service volume and inflation-adjusted Medicare reimbursement of vitreoretinal procedures over the past 2 decades. Methods: Medicare Part B National Summary Data Files were accessed to identify the number of allowed services for vitreoretinal procedures. The Medicare Physician Fee Schedule was accessed to identify average annual national reimbursement rates. The Spearman correlation coefficient was used to evaluate time trends for each procedure. All analyses were conducted using Prism 9.5.1 software with 2-sided significance testing and statistical significance set at P ≤ .05. Results: From 2000 to 2021, the 2-tailed Spearman correlation showed that 20 of 38 procedures had statistically significant decreases in service volume over time. Intravitreal injections increased more than 1000-fold, from 2922 in 2000 to 3 444 500 injections in 2021 (ρ = 0.997; P < .001). Panretinal photocoagulation treatments declined from 104 865 to 48 533 procedures (ρ = -0.966; P = .003). Scleral buckling declined from 6502 to 587 procedures (ρ = -0.999; P < .001). Pars plana vitrectomy-associated procedures increased from 71 039 to 95 429 (ρ = 0.691; P < .001). From 2000 to 2021, the 2-tailed Spearman correlation showed that 29 of 38 procedures had statistically significant decreases in reimbursement over time. No procedure had a significant increase in payment. Conclusions: Vitreoretinal practice patterns have changed dramatically over the past 2 decades, with significant declines in inflation-adjusted Medicare reimbursement for most procedures. Awareness of service volume and reimbursement trends is vital to assessing economic viability and patient coverage under the current Medicare payment policies.

目的:描述过去二十年来玻璃体视网膜手术的服务量和通货膨胀调整后的医疗保险报销趋势。方法:访问医疗保险 B 部分国家汇总数据文件,以确定玻璃体视网膜手术的允许服务数量。查阅医疗保险医生收费表,确定全国年平均报销率。斯皮尔曼相关系数用于评估每项手术的时间趋势。所有分析均使用 Prism 9.5.1 软件进行,采用双侧显著性检验,统计显著性设定为 P≤ .05。结果:从 2000 年到 2021 年,双尾斯皮尔曼相关性显示,38 种手术中有 20 种的服务量随时间推移出现了统计学意义上的显著下降。玻璃体内注射增加了 1000 多倍,从 2000 年的 2922 次增加到 2021 年的 3 444 500 次(ρ = 0.997;P P = .003)。巩膜扣带术从 6502 例减少到 587 例(ρ = -0.999;P P 结论:巩膜扣带术的数量从 2000 年的 2922 例增加到 2021 年的 3 444 500 例:在过去的 20 年中,玻璃体视网膜手术的模式发生了巨大变化,大多数手术的医疗保险报销额度在通货膨胀调整后大幅下降。在现行的医疗保险支付政策下,了解服务量和报销趋势对于评估经济可行性和患者覆盖率至关重要。
{"title":"Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021.","authors":"Eric S Li, Ron A Adelman","doi":"10.1177/24741264241292743","DOIUrl":"10.1177/24741264241292743","url":null,"abstract":"<p><p><b>Purpose:</b> To characterize trends in service volume and inflation-adjusted Medicare reimbursement of vitreoretinal procedures over the past 2 decades. <b>Methods</b>: Medicare Part B National Summary Data Files were accessed to identify the number of allowed services for vitreoretinal procedures. The Medicare Physician Fee Schedule was accessed to identify average annual national reimbursement rates. The Spearman correlation coefficient was used to evaluate time trends for each procedure. All analyses were conducted using Prism 9.5.1 software with 2-sided significance testing and statistical significance set at <i>P</i> ≤ .05. <b>Results:</b> From 2000 to 2021, the 2-tailed Spearman correlation showed that 20 of 38 procedures had statistically significant decreases in service volume over time. Intravitreal injections increased more than 1000-fold, from 2922 in 2000 to 3 444 500 injections in 2021 (ρ = 0.997; <i>P</i> < .001). Panretinal photocoagulation treatments declined from 104 865 to 48 533 procedures (ρ = -0.966; <i>P</i> = .003). Scleral buckling declined from 6502 to 587 procedures (ρ = -0.999; <i>P</i> < .001). Pars plana vitrectomy-associated procedures increased from 71 039 to 95 429 (ρ = 0.691; <i>P</i> < .001). From 2000 to 2021, the 2-tailed Spearman correlation showed that 29 of 38 procedures had statistically significant decreases in reimbursement over time. No procedure had a significant increase in payment. <b>Conclusions:</b> Vitreoretinal practice patterns have changed dramatically over the past 2 decades, with significant declines in inflation-adjusted Medicare reimbursement for most procedures. Awareness of service volume and reimbursement trends is vital to assessing economic viability and patient coverage under the current Medicare payment policies.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241292743"},"PeriodicalIF":0.5,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exudative Vitreoretinopathy With a Coats-Like Response in Poretti-Boltshauser Syndrome. 波雷蒂-博尔特豪泽综合征伴有类似外套反应的渗出性玻璃体视网膜病变
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-11-08 DOI: 10.1177/24741264241296465
Serena Shah, Natasha Ferreira Santos da Cruz, Francisco Lopez-Font, Patrick Staropoli, Audina Berrocal

Purpose: To report a unique case of retinal exudation consistent with a Coats-like response and associated with mutations in LAMA1, confirming the diagnosis of Poretti-Boltshauser syndrome. Methods: A case and its findings were analyzed. Results: A 24-year-old woman presented with mild peripheral avascularity, circumferential membranes at the edge of the vascularized retina, exudation, numerous vessels with aneurysmal changes, and inferior retinal elevation in both eyes. Molecular Vision Laboratory panel testing (Molecular Vision Laboratory Corp) found 2 variants in the LAMA1 gene, confirming a diagnosis of Poretti-Boltshauser syndrome. Treatment with bevacizumab and sub-Tenon triamcinolone provided no improvement. Eventually, scleral buckling with pars plana vitrectomy was performed, which reattached the retina but did not improve visual acuity. Conclusions: This report shows the importance of investigating for an underlying genetic disorder in young patients with atypical exudation and abnormal vasculature and the persistent progression and challenging treatment course of patients presenting with Poretti-Boltshauser syndrome.

目的:报告一例独特的视网膜渗出病例,该病例与 Coats-like 反应一致,并与 LAMA1 基因突变有关,确诊为 Poretti-Boltshauser 综合征。方法:分析一个病例及其研究结果。结果一名 24 岁的女性患者出现轻度周边血管缺损、血管视网膜边缘周膜、渗出、大量血管瘤样变、双眼视网膜下部隆起。分子视觉实验室面板检测(Molecular Vision Laboratory Corp)发现了 LAMA1 基因的两个变体,确诊为波雷蒂-博尔特豪泽综合征。贝伐珠单抗和腱膜下曲安奈德治疗效果不佳。最后,患者接受了巩膜扣带术和玻璃体旁切除术,重新接合了视网膜,但视力并未得到改善。结论:本报告表明,对于患有非典型渗出和异常血管的年轻患者,调查潜在遗传疾病非常重要,而且波雷蒂-博尔特豪泽综合征患者的病情会持续恶化,治疗过程也充满挑战。
{"title":"Exudative Vitreoretinopathy With a Coats-Like Response in Poretti-Boltshauser Syndrome.","authors":"Serena Shah, Natasha Ferreira Santos da Cruz, Francisco Lopez-Font, Patrick Staropoli, Audina Berrocal","doi":"10.1177/24741264241296465","DOIUrl":"10.1177/24741264241296465","url":null,"abstract":"<p><p><b>Purpose:</b> To report a unique case of retinal exudation consistent with a Coats-like response and associated with mutations in <i>LAMA1</i>, confirming the diagnosis of Poretti-Boltshauser syndrome. <b>Methods:</b> A case and its findings were analyzed. <b>Results:</b> A 24-year-old woman presented with mild peripheral avascularity, circumferential membranes at the edge of the vascularized retina, exudation, numerous vessels with aneurysmal changes, and inferior retinal elevation in both eyes. Molecular Vision Laboratory panel testing (Molecular Vision Laboratory Corp) found 2 variants in the <i>LAMA1</i> gene, confirming a diagnosis of Poretti-Boltshauser syndrome. Treatment with bevacizumab and sub-Tenon triamcinolone provided no improvement. Eventually, scleral buckling with pars plana vitrectomy was performed, which reattached the retina but did not improve visual acuity. <b>Conclusions:</b> This report shows the importance of investigating for an underlying genetic disorder in young patients with atypical exudation and abnormal vasculature and the persistent progression and challenging treatment course of patients presenting with Poretti-Boltshauser syndrome.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241296465"},"PeriodicalIF":0.5,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical Coherence Tomography Angiography in Macular Neovascularization Secondary to Focal Choroidal Excavation. 病灶脉络膜切除术继发黄斑新生血管的光学相干断层扫描血管造影。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-10-30 DOI: 10.1177/24741264241294159
Riley C T Duke, Shambhavi Anshumali, Jason N Crosson

Purpose: To highlight the use of multimodal imaging for detecting and monitoring macular neovascularization (MNV) in the presence of focal choroidal excavation. Methods: A case and its findings were analyzed. Results: Spectral-domain optical coherence tomography (OCT) and OCT angiography (OCTA) were performed in a 30-year-old Asian woman with metamorphopsia in the left eye. Imaging showed striking MNV secondary to focal choroidal excavation, and an impressive response to antivascular endothelial growth factor therapy was seen throughout the follow-up. Conclusions: OCTA is a noninvasive, useful imaging modality for diagnosing and monitoring patients with MNV secondary to focal choroidal excavation.

目的:强调多模态成像在检测和监测存在局灶脉络膜挖掘的黄斑新生血管(MNV)方面的应用。方法:对一个病例及其结果进行分析:分析一个病例及其研究结果。结果:发现了黄斑新生血管:对一名左眼变形的 30 岁亚洲女性进行了光谱域光学相干断层扫描(OCT)和 OCT 血管造影(OCTA)检查。成像结果显示,继发于局灶性脉络膜挖出的 MNV 非常明显,在整个随访期间,患者对抗血管内皮生长因子治疗的反应非常好。结论:OCTA 是一种无创、有用的成像模式,可用于诊断和监测继发于局灶性脉络膜挖出的 MNV 患者。
{"title":"Optical Coherence Tomography Angiography in Macular Neovascularization Secondary to Focal Choroidal Excavation.","authors":"Riley C T Duke, Shambhavi Anshumali, Jason N Crosson","doi":"10.1177/24741264241294159","DOIUrl":"10.1177/24741264241294159","url":null,"abstract":"<p><p><b>Purpose:</b> To highlight the use of multimodal imaging for detecting and monitoring macular neovascularization (MNV) in the presence of focal choroidal excavation. <b>Methods:</b> A case and its findings were analyzed. <b>Results:</b> Spectral-domain optical coherence tomography (OCT) and OCT angiography (OCTA) were performed in a 30-year-old Asian woman with metamorphopsia in the left eye. Imaging showed striking MNV secondary to focal choroidal excavation, and an impressive response to antivascular endothelial growth factor therapy was seen throughout the follow-up. <b>Conclusions:</b> OCTA is a noninvasive, useful imaging modality for diagnosing and monitoring patients with MNV secondary to focal choroidal excavation.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241294159"},"PeriodicalIF":0.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis. 一名患有慢性后葡萄膜炎的年轻人因霉酚酸酯诱发淋巴组织增生性疾病。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-10-30 DOI: 10.1177/24741264241294165
Nabiha B Habib, Joseph Boss

Purpose: To present a case of a young adult with bilateral chronic posterior uveitis resulting from Vogt-Koyanagi-Harada (VKH) disease treated with mycophenolate mofetil who subsequently developed vitreoretinal lymphoma in the right eye. Methods: A case and its findings were analyzed. Results: A 34-year-old Hispanic woman presented with an 8-year history of chronic recurrent posterior uveitis in both eyes secondary to VKH disease. A vitreous infiltrate that was treatment resistant occurred in the right eye. Subsequently, a diagnostic vitrectomy was performed, and it was determined that the patient had developed unilateral vitreoretinal lymphoma. Conclusions: Masquerade syndromes should remain in the differential in patients with well-established uveitis who are on immunomodulatory treatment. A diagnostic vitrectomy should be considered when the treatment response is uncharacteristic. Furthermore, guidelines are lacking for central nervous system prophylaxis for isolated unilateral ocular intraocular lymphoma in young adults.

目的:介绍一例因 Vogt-Koyanagi-Harada(VKH)病引起的双侧慢性后葡萄膜炎患者,患者曾接受霉酚酸酯治疗,但随后右眼发生玻璃体视网膜淋巴瘤。方法:对一个病例及其结果进行分析。结果:一名 34 岁的西班牙裔女性因继发于 VKH 病,双眼慢性复发性后葡萄膜炎病史长达 8 年。右眼出现玻璃体浸润,且对治疗耐药。随后,医生对其进行了诊断性玻璃体切除术,确定患者患上了单侧玻璃体视网膜淋巴瘤。结论:对于接受免疫调节治疗的已确诊葡萄膜炎患者,假性综合征仍应在鉴别诊断之列。当治疗反应不典型时,应考虑进行诊断性玻璃体切除术。此外,目前还缺乏针对青壮年孤立性单侧眼内淋巴瘤的中枢神经系统预防指南。
{"title":"Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis.","authors":"Nabiha B Habib, Joseph Boss","doi":"10.1177/24741264241294165","DOIUrl":"10.1177/24741264241294165","url":null,"abstract":"<p><p><b>Purpose:</b> To present a case of a young adult with bilateral chronic posterior uveitis resulting from Vogt-Koyanagi-Harada (VKH) disease treated with mycophenolate mofetil who subsequently developed vitreoretinal lymphoma in the right eye. <b>Methods:</b> A case and its findings were analyzed. <b>Results:</b> A 34-year-old Hispanic woman presented with an 8-year history of chronic recurrent posterior uveitis in both eyes secondary to VKH disease. A vitreous infiltrate that was treatment resistant occurred in the right eye. Subsequently, a diagnostic vitrectomy was performed, and it was determined that the patient had developed unilateral vitreoretinal lymphoma. <b>Conclusions:</b> Masquerade syndromes should remain in the differential in patients with well-established uveitis who are on immunomodulatory treatment. A diagnostic vitrectomy should be considered when the treatment response is uncharacteristic. Furthermore, guidelines are lacking for central nervous system prophylaxis for isolated unilateral ocular intraocular lymphoma in young adults.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241294165"},"PeriodicalIF":0.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Surgical Approach for Repair of Refractory Macular Hole in Myopic Traction Maculopathy. 修复近视牵引性黄斑病变难治性黄斑孔的联合手术方法
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-10-30 DOI: 10.1177/24741264241293908
Barbara Parolini, Veronika Matello, Jaime Francisco Rosales-Padrón

Purpose: To present a combined surgical approach for repair of a persistent full-thickness macular hole (MH) in patients with myopic traction maculopathy. Methods: Two cases were evaluated. Results: Combining a macular buckle and pars plana vitrectomy with a controlled subretinal injection of a balanced salt solution resulted in MH closure and vision improvement in both cases. Case 1 also had significant recovery of macular sensitivity on microperimetry evaluation. Conclusions: Retinal redetachment was avoided by using the buckle indentation to provide external support of the posterior pole, resulting in successful closure of the MH and improvement in functional outcomes.

目的:介绍一种修复近视牵引性黄斑病变患者持续性全厚黄斑孔(MH)的联合手术方法。方法:评估两个病例:对两个病例进行评估。结果:结合黄斑扣带术和玻璃体旁切除术,并控制性地在视网膜下注射平衡盐溶液,两例患者的黄斑孔均闭合,视力均有改善。病例 1 在微测力评估中黄斑灵敏度也有明显恢复。结论:利用扣带压痕为后极部提供外部支撑,避免了视网膜再剥离,从而成功关闭了 MH 并改善了功能。
{"title":"Combined Surgical Approach for Repair of Refractory Macular Hole in Myopic Traction Maculopathy.","authors":"Barbara Parolini, Veronika Matello, Jaime Francisco Rosales-Padrón","doi":"10.1177/24741264241293908","DOIUrl":"10.1177/24741264241293908","url":null,"abstract":"<p><p><b>Purpose:</b> To present a combined surgical approach for repair of a persistent full-thickness macular hole (MH) in patients with myopic traction maculopathy. <b>Methods:</b> Two cases were evaluated. <b>Results:</b> Combining a macular buckle and pars plana vitrectomy with a controlled subretinal injection of a balanced salt solution resulted in MH closure and vision improvement in both cases. Case 1 also had significant recovery of macular sensitivity on microperimetry evaluation. <b>Conclusions:</b> Retinal redetachment was avoided by using the buckle indentation to provide external support of the posterior pole, resulting in successful closure of the MH and improvement in functional outcomes.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241293908"},"PeriodicalIF":0.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal Imaging of a Unique Transitory Finding in Ocular Syphilis. 眼梅毒独特短暂发现的多模态成像
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-10-30 DOI: 10.1177/24741264241277407
James P Winebrake, Dawn Chirko, Thanos Papakostas, Kyle D Kovacs

Purpose: To describe a unique finding in ocular syphilis using multimodal imaging. Methods: A single case was analyzed. Results: A 52-year-old man presented with chronic syphilitic posterior uveitis and was treated with intravenous and intramuscular penicillin for systemic manifestations, topical steroids, and unilateral bevacizumab for secondary macular neovascularization. Bilateral transitory outer retinal microcysts were subsequently seen on optical coherence tomography, with an appearance distinct from outer retinal lesions found in other degenerative retinal diseases. Conclusions: Longstanding smoldering inflammation in this patient resulted in retinal pigment epithelial disruption and subsequent overlying photoreceptor rearrangement with microcyst formation. The spontaneous resolution and reappearance of these lesions elsewhere, despite previous treatment, may offer further insight into localized retinal tissue response from treponemal disease.

目的:利用多模态成像技术描述眼梅毒的独特发现。方法:对一个病例进行分析:分析一个病例。结果:一名 52 岁男子患有慢性梅毒性后葡萄膜炎,接受了梅毒治疗:一名 52 岁的男性患有慢性梅毒性后葡萄膜炎,接受了静脉注射和肌肉注射青霉素治疗全身表现、局部类固醇治疗以及单侧贝伐单抗治疗继发性黄斑新生血管。随后在光学相干断层扫描中发现了双侧过渡性视网膜外层微囊瘤,其外观与其他退行性视网膜疾病中发现的视网膜外层病变截然不同。结论:该患者长期的淤积性炎症导致视网膜色素上皮破坏,随后上覆的感光细胞重排并形成微囊藻。尽管之前接受过治疗,但这些病变在其他部位自发消退并再次出现,这可能会让人进一步了解三联体疾病引起的局部视网膜组织反应。
{"title":"Multimodal Imaging of a Unique Transitory Finding in Ocular Syphilis.","authors":"James P Winebrake, Dawn Chirko, Thanos Papakostas, Kyle D Kovacs","doi":"10.1177/24741264241277407","DOIUrl":"10.1177/24741264241277407","url":null,"abstract":"<p><p><b>Purpose:</b> To describe a unique finding in ocular syphilis using multimodal imaging. <b>Methods:</b> A single case was analyzed. <b>Results:</b> A 52-year-old man presented with chronic syphilitic posterior uveitis and was treated with intravenous and intramuscular penicillin for systemic manifestations, topical steroids, and unilateral bevacizumab for secondary macular neovascularization. Bilateral transitory outer retinal microcysts were subsequently seen on optical coherence tomography, with an appearance distinct from outer retinal lesions found in other degenerative retinal diseases. <b>Conclusions:</b> Longstanding smoldering inflammation in this patient resulted in retinal pigment epithelial disruption and subsequent overlying photoreceptor rearrangement with microcyst formation. The spontaneous resolution and reappearance of these lesions elsewhere, despite previous treatment, may offer further insight into localized retinal tissue response from treponemal disease.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241277407"},"PeriodicalIF":0.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of VitreoRetinal Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1